Form 4: Lemaitre Vascular Director Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Lawrence J Jasinski, a Director of Lemaitre Vascular Inc, reported multiple transactions in common stock on September 3, 2026.

Summary

  • Grant/award: acquired 1 Dividend Equivalent Rights on September 3, 2026; holds 6 after (Direct).
  • Grant/award: acquired 1 Dividend Equivalent Rights on September 3, 2026; holds 6 after (Direct).
  • Grant/award: acquired 1 Dividend Equivalent Rights on September 3, 2026; holds 5 after (Direct).
  • Grant/award: acquired 1 Dividend Equivalent Rights on September 3, 2026; holds 5 after (Direct).
  • Grant/award: acquired 2 Dividend Equivalent Rights on September 3, 2026; holds 4 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Lawrence J Jasinski — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-09-03Grant/awardDividend Equivalent Rights0.543——5.61
2026-09-03Grant/awardDividend Equivalent Rights0.65——5.52
2026-09-03Grant/awardDividend Equivalent Rights0.885——5.184
2026-09-03Grant/awardDividend Equivalent Rights1.002——5.486
2026-09-03Grant/awardDividend Equivalent Rights1.664——4.299

Key Dates

DateDescription
2026-09-03Grant/award (1 shares)
2026-09-03Grant/award (1 shares)
2026-09-03Grant/award (1 shares)
2026-09-03Grant/award (1 shares)
2026-09-03Grant/award (2 shares)

Keywords

insider transaction, Form 4, LMAT, LEMAITRE VASCULAR INC, neutral, Lawrence J Jasinski

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.